Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jan 16, 2015 9:21am
71 Views
Post# 23327085

RE:RE:RE:RE:RE:Brain cancer

RE:RE:RE:RE:RE:Brain cancer
Macer wrote: Interesting in regards to the type of cancer mentioned in these posts. The cerebral spinal space is filled with fluid (cerebral spinal fluid) that communicates the spinal column to the visceral surfaces of the brain itself. This space is accessable and is commonly cannulated to allow for spinal/epidural anesthesia, where the anesthitist can infuse medication to allow for spinal anesthesia. Theoretically PDC's could be infused into this space as well in the same manner that the bladder is infused (a little more  tricky maybe). They could then apply light and treat the patient , possibly non-invasivly.
There would be obvious differences in these treatments for sure but interseting that this was mentioned in the news today.

Position yourself accordingly.

Macer



Another great post. Possibly easier to target spinal indications... anyone have market sizes on this area? Available treatments? Orphan status? Fasttrack eligible?
Bullboard Posts